Literature DB >> 20835694

[Total pelvic exenteration].

U Heger1, M Koch, M W Büchler, J Weitz.   

Abstract

Over the last decades total pelvic exenteration (TPE) has evolved into an established and safe surgical technique for locally advanced pelvic malignancies. Depending on the type of cancer 5 year overall survival rates of up to 66% and a satisfactory postsurgical quality of life have been reported. Currently infiltration of the pelvic side wall and resectable metastases are not necessarily a contraindication to a curative approach; furthermore, TPE can also be useful in palliative surgery. In locally recurrent rectal cancer TPE is the treatment of choice if the tumor is deemed resectable. A multidisciplinary diagnostic and therapeutic approach is of utmost importance, hence patients should be treated in specialized centers.

Entities:  

Mesh:

Year:  2010        PMID: 20835694     DOI: 10.1007/s00104-010-1945-z

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  17 in total

1.  Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?

Authors:  Nuh N Rahbari; Alexis B Ulrich; Thomas Bruckner; Marc Münter; Axel Nickles; Pietro Contin; Thorsten Löffler; Christoph Reissfelder; Moritz Koch; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

2.  Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer.

Authors:  M G Guren; J N Wiig; S Dueland; K M Tveit; S D Fosså; H Waehre; K E Giercksky
Journal:  Eur J Surg Oncol       Date:  2001-11       Impact factor: 4.424

3.  Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy.

Authors:  A BRUNSCHWIG
Journal:  Cancer       Date:  1948-07       Impact factor: 6.860

4.  Pelvic exenteration without external urinary or fecal diversion in gynecological cancer patients.

Authors:  L Ungar; L Palfalvi
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

5.  Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.

Authors:  M Vermaas; F T J Ferenschild; C Verhoef; J J M E Nuyttens; A W K S Marinelli; T Wiggers; W J Kirkels; A M M Eggermont; J H W de Wilt
Journal:  Eur J Surg Oncol       Date:  2006-10-30       Impact factor: 4.424

6.  Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience.

Authors:  Matías Jurado; Juan Luis Alcázar; Rafael Martinez-Monge
Journal:  Gynecol Oncol       Date:  2009-10-29       Impact factor: 5.482

7.  Reconstruction of the pelvic floor and perineum with human acellular dermal matrix and thigh flaps following pelvic exenteration.

Authors:  Hakim K Said; Michael Bevers; Charles E Butler
Journal:  Gynecol Oncol       Date:  2007-10-04       Impact factor: 5.482

8.  Presentation and prognosis of local recurrence after total mesorectal excision.

Authors:  C de Chaisemartin; C Penna; D Goere; S Benoist; A Beauchet; C Julie; B Nordlinger
Journal:  Colorectal Dis       Date:  2008-04-28       Impact factor: 3.788

9.  Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration.

Authors:  Dirk Michael Forner; Ansgar Meyer; Bjoern Lampe
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-11-17       Impact factor: 2.435

10.  Total pelvic exenteration for primary and recurrent malignancies.

Authors:  F T J Ferenschild; M Vermaas; C Verhoef; A C Ansink; W J Kirkels; A M M Eggermont; J H W de Wilt
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

View more
  2 in total

1.  [Palliative radical (cysto)prostatectomy in locally advanced castration-resistant prostate cancer].

Authors:  D Pfister; D Porres; R Epplen; T von Erps; A Heidenreich
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  Locally recurrent colorectal cancer: results of surgical therapy.

Authors:  M Kruschewski; M Ciurea; S Lipka; S Daum; L Moser; B Meyer; J Gröne; J Budczies; H J Buhr
Journal:  Langenbecks Arch Surg       Date:  2012-06-28       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.